e-z cinnamic acid has been researched along with Alzheimer Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Irie, K; Isoda, H; Kurisu, M; Miyamae, Y; Murakami, K; Shigemori, H | 1 |
| Decker, M; Gutmann, M; Hofmann, J; Maurice, T; Spatz, P; Walther, R | 1 |
| Cao, B; Feng, WS; Hao, FX; Jiao, XM; Liang, XW; Zeng, MN; Zheng, XK | 1 |
| Ávila-Cossío, ME; Carranza-Ambriz, KP; Córdova-Guerrero, I; Cornejo-Bravo, JM; Cota-Ramírez, BR; Estolano-Cobián, A; Martinez, AL; Ramírez-Ruiz, AM; Rivero, IA; Serrano-Medina, A | 1 |
| Feng, F; Jiang, P; Li, Q; Liao, Q; Liu, W; Qu, W; Sun, H; Yan, Y; Zhao, Y | 1 |
| He, Y; Liu, S; Liu, W; Mi, J; Sang, Z; Shi, J; Tan, Z; Tang, X; Wang, K; Yang, J; Zhou, Y | 1 |
| Ding, Y; Hou, JW; Lan, JS; Li, L; Liu, Y; Zhang, T; Zhang, Y | 1 |
| Bian, Y; Chen, J; Chen, Y; Gu, K; Hou, J; Jiang, X; Lin, H; Lv, Y; Mo, J; Pei, Y; Sun, H; Tan, R; Wu, L; Yang, H; Zhu, J | 1 |
| Shigemori, H; Takase, M; Tsunoda, T | 1 |
| Chandra, S; Jana, M; Pahan, K; Roy, A | 1 |
| Di Somma, S; Ferraro, G; Florio, D; Iacobucci, I; Malfitano, AM; Marasco, D; Merlino, A; Monti, M; Morelli, G; Mügge, C; Weigand, W | 1 |
| Andrisano, V; Bartolini, M; Caporaso, R; Fiori, J; Lanni, C; Minarini, A; Necchi, D; Pinto, A; Rosini, M; Serafini, MM; Simoni, E | 1 |
12 other study(ies) available for e-z cinnamic acid and Alzheimer Disease
| Article | Year |
|---|---|
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Humans; Neurons; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; Quinic Acid; Structure-Activity Relationship | 2012 |
Synthesis and Biological Evaluation of Flavonoid-Cinnamic Acid Amide Hybrids with Distinct Activity against Neurodegeneration in Vitro and in Vivo.
Topics: Alzheimer Disease; Amides; Animals; Biological Products; Cinnamates; Flavonoids; Mice; Quercetin; Silybin | 2022 |
[Effect of aqueous extract of Corni Fructus on Aβ_(25-35)-induced brain injury and neuroinflammation in mice with Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspartic Acid; Brain Injuries; Cornus; Cysteine; Disease Models, Animal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Docking Simulation; Neuroinflammatory Diseases; Peptide Hydrolases; Tumor Necrosis Factor-alpha | 2023 |
Inhibitory Activity of 4-Benzylidene Oxazolones Derivatives of Cinnamic Acid on Human Acetylcholinesterase and Cognitive Improvements in a Mouse Model.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Humans; Mice; Molecular Docking Simulation; Oxazolone; Structure-Activity Relationship | 2023 |
Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Carbolines; Cell Survival; Cinnamates; Dose-Response Relationship, Drug; Drug Design; Humans; Male; Maze Learning; Mice; Mice, Inbred ICR; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Cinnamates; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Reactive Oxygen Species; Structure-Activity Relationship | 2021 |
Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cholinesterase Inhibitors; Cholinesterases; Cinnamates; Dose-Response Relationship, Drug; Drug Design; Humans; Mice; Mice, Inbred Strains; Molecular Structure; PC12 Cells; Peptide Fragments; Protein Aggregates; Pyridinium Compounds; Rats; Structure-Activity Relationship | 2017 |
Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Cinnamates; Dose-Response Relationship, Drug; Electrophorus; Horses; Humans; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Protein Aggregates; Structure-Activity Relationship; Tacrine | 2018 |
Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid β aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cacao; Catechols; Cinnamates; Dihydroxyphenylalanine; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Tyrosine | 2018 |
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model.
Topics: Alzheimer Disease; Animals; Cinnamates; Disease Models, Animal; Female; Lysosomes; Male; Mice; Plaque, Amyloid; PPAR alpha | 2019 |
Platinum(II)
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Benzothiazoles; Cell Line; Cinnamates; Circular Dichroism; Coordination Complexes; Humans; Ligands; Nuclear Proteins; Nucleophosmin; Peptide Termination Factors; Platinum; Protein Aggregation, Pathological; Saccharomyces cerevisiae Proteins | 2019 |
Nature-Inspired Multifunctional Ligands: Focusing on Amyloid-Based Molecular Mechanisms of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cinnamates; Humans; Hydrogen Peroxide; Ligands; Oxidative Stress; Protective Agents; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Signal Transduction; Tumor Suppressor Protein p53; Zyxin | 2016 |